Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Deerfield Management/Activity

Deerfield Management Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Launched 3DC-incubated Boulevard Bio with $65M from Deerfield and a precision-immunology pipeline led by BLVD101.

Boulevard Bio

Boulevard Bio Deerfield Management

prnewswire.comAUG 12, 2026

AUG 12, 2026

News

Ranked #10 among biotech-focused venture investors in the inaugural 2026 Strebulaev-Jackson Venture Ranking.

2026 Strebulaev-Jackson Venture Ranking - Biotech #10

Deerfield Management

ilyastrebulaev.substack.comAUG 2026

AUG 2026

Investment

Participated as a follow-on investor in Ray Therapeutics upsized $125M Series B, led by Janus Henderson Investors, for optogenetic vision-restoration therapies.

Ray Therapeutics

Ray Therapeutics Deerfield Management

businesswire.comAPR 21, 2026

APR 21, 2026

Investment

Led Neomorph Series B ($100M) for molecular glue degrader therapeutics, with Regeneron Ventures, Longwood Fund, Alexandria Venture Investments, and Binney Street Capital participating.

Neomorph

Neomorph Deerfield Management

neomorph.comAPR 13, 2026

APR 13, 2026

New Fund

Closed Deerfield Healthcare Innovations Fund III at over $600M to invest in therapeutics, care-delivery models, and AI/ML-enabled healthcare technologies.

Deerfield Healthcare Innovations Fund III

Deerfield Management

prnewswire.comMAY 5, 2025

MAY 5, 2025

Investment

Led Ascertain Series A ($10M) for AI care-management agents automating clinical administrative workflows.

Ascertain

Ascertain Deerfield Management

axios.comAPR 22, 2025

APR 22, 2025

Deerfield Management | Activity | F4